ArticleOncotarget2017

Endostar in combination with postoperative adjuvant chemotherapy prolongs the disease free survival of stage IIIA NSCLC patients with high VEGF expression.

Zhiwei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.